Notably, the expression levels of HOXD10 were related to clinical stage (P < 0.05) but not to age, sex, lymph node metastasis, or pathological differentiation (P > 0.05) (Table 1). Here, HOXD10 is linked to metastatic malignant neoplasm in the lymph nodes.